Abstract:Stroke is a leading cause of long-term disability. All neuroprotectants targeting excitotoxicity have failed to become stroke medications. In order to explore and identify new therapeutic targets for stroke, we here reviewed present studies of ionic transporters and channels that are involved in ischemic brain damage.We surveyed recent literature from animal experiments and clinical reports in the databases of PubMed and Elsevier ScienceDirect to analyze ionic mechanisms underlying ischemic cell damage and suggest promising ideas for stroke therapy.Dysfunction of ionic transporters and disrupted ionic homeostasis are most early changes that underlie ischemic brain injury, thus receiving sustained attention in translational stroke research. The Na(+)/K(+)-ATPase, Na(+)/Ca(2+) Exchanger, ionotropic glutamate receptor, acid-sensing ion channels (ASICs), sulfonylurea receptor isoform 1 (SUR1)-regulated NCCa-ATP channels, and transient receptor potential (TRP) channels are critically involved in ischemia-induced cellular degenerating processes such as cytotoxic edema, excitotoxicity, necrosis, apoptosis, and autophagic cell death. Some ionic transporters/channels also act as signalosomes to regulate cell death signaling. For acute stroke treatment, glutamate-mediated excitotoxicity must be interfered within 2 hours after stroke. The SUR1-regulated NCCa-ATP channels, Na(+)/K(+)-ATPase, ASICs, and TRP channels have a much longer therapeutic window, providing new therapeutic targets for developing feasible pharmacological treatments toward acute ischemic stroke.The next generation of stroke therapy can apply a polypharmacology strategy for which drugs are designed to target multiple ion transporters/channels or their interaction with neurotoxic signaling pathways. But a successful translation of neuroprotectants relies on in-depth analyses of cell death mechanisms and suitable animal models resembling human stroke.

Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke

Blood–Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke

CNS Drug Delivery in Stroke: Improving Therapeutic Translation From the Bench to the Bedside

Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection

Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke

Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics

Advanced Drug Delivery System Against Ischemic Stroke

Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke

Savaging Brain Ischemia by Increasing Brain Uptake of Neuroprotectants

Brain Drug Delivery Systems for the Stroke Intervention and Recovery.

Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke

Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier

Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system

Current Strategies for Brain Drug Delivery

Nanotechnology approaches to drug delivery for the treatment of ischemic stroke

New progress in the approaches for blood–brain barrier protection in acute ischemic stroke

Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets.